Hugues Abriel studied life sciences at the Swiss Federal Institute of Technology in Zurich (ETHZ, 1989) and medicine at the University of Lausanne (MD, 1994). He received a PhD degree in Physiology from the University of Lausanne in Switzerland (1995). He has spent two years as a research scientist at Columbia University in New York, USA.
Hugues Abriel has been a group leader (2002-2009) at the Department of Pharmacology and Toxicology at the University of Lausanne thanks to a professorship from the Swiss National Science Foundation (SNSF-Professor). From 2009 until 2016, he was the Director of the Department of Clinical Research of the University of Bern at the Inselspital, and professor of pathophysiology. In 2012, he was elected as a member of the research council of the SNSF, and he is since 2016 vice-president of the division of biology and medicine. He is the director since 2015 of the SNSF-funded research network NCCR TransCure.
His research work focuses on the roles of ion channels in human diseases (channelopathies). Currently, he is mainly exploring the genetic, molecular and cellular bases of cardiac arrhythmias.
Personal Website: Abriel Group
Function in NCCR
- NCCR Director
- Principal Investigator (PI)
- Management Comm. Member
- Delegate for Equal Opportunities
Managing Director, Institute of Biochemistry and Molecular Medicine, University of Bern
Director, Department of Clinical Research, University of Bern
- Ph.D. in Physiology at the University of Lausanne
- M.D. in Physiology at the University of Lausanne
- M.Sc. in Life Sciences at the Swiss Federal Institute of Technology, Zurich
- The Physiological Society
- European Society Cardiology
- The American Physiological Society
- American Heart Association
- Novartis-Prize, Cardiovascular Biology meeting, Thun
- Awards of the Swiss National Science Foundation: SNF-Professorship
- Awards of the Swiss Foundation for Fellowships in Medicine and Biology for a 2-year fellowship